Raul R. Rodriguez - Feb 4, 2025 Form 4 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)

Role
CEO, President, Director
Signature
/s/ Raymond Furey (Attorney-in-Fact)
Stock symbol
RIGL
Transactions as of
Feb 4, 2025
Transactions value $
-$200,075
Form type
4
Date filed
2/6/2025, 08:27 PM
Previous filing
Jan 31, 2025
Next filing
Mar 19, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RIGL Common Stock Sale -$104K -4.95K -1.99% $20.92 244K Feb 4, 2025 Direct F1
transaction RIGL Common Stock Sale -$96.5K -4.4K -1.8% $21.93 239K Feb 5, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.